FOUGERA PHARMACEUTICALS INC. et al v. TOLMAR, INC. > Summary
Court Case Number 2:10-cv-02635
Filing Date May 21, 2010
Termination Date Aug 8, 2011
Court New Jersey District Court
Status Statistical Closing
Plaintiff Attorneys
8FOUGERA PHARMACEUTICALS INC.
Attorney Name: Albert B. Chen
Kramer Levin Naftalis & Frankel
FOUGERA PHARMACEUTICALS INC.
Attorney Name: Michael J. Gesualdo
Robinson Miller
Jagotec AG
Attorney Name: Michael J. Gesualdo
Robinson Miller
FOUGERA PHARMACEUTICALS INC.
Attorney Name: William J. O'Shaughnessy
McCarter & English
Jagotec AG
Attorney Name: Jason S. Oliver
Baker & Hostetler LLP
FOUGERA PHARMACEUTICALS INC.
Attorney Name: Leda D. Wettre
Robinson Miller
Jagotec AG
Attorney Name: Leda D. Wettre
Robinson Miller
Defendant Attorneys
2Tolmar, Inc.
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Tolmar, Inc.
Attorney Name: Christina Saveriano
Hill Wallack LLP
Counter Defendant
6FOUGERA PHARMACEUTICALS INC.
Attorney Name: Albert B. Chen
Kramer Levin Naftalis & Frankel
FOUGERA PHARMACEUTICALS INC.
Attorney Name: William J. O'Shaughnessy
McCarter & English
Jagotec AG
Attorney Name: Jason S. Oliver
Baker & Hostetler LLP
Jagotec AG
Attorney Name: Leda D. Wettre
Robinson Miller
FOUGERA PHARMACEUTICALS INC.
Attorney Name: Leda D. Wettre
Robinson Miller
Counter Claimant
6Tolmar, Inc.
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Tolmar, Inc.
Attorney Name: Christina Saveriano
Hill Wallack LLP
Attorney Name: Kevin P. Shortsle
Attorney Name: Brent A. Hawkins
Attorney Name: Rita J. Yoon
Attorney Name: Jeffrey R. Gargano
Cause
35:145 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
05985850 | Compositions comprising hyaluronic acid and drugs | Nov 16, 1999 |
05929048 | Treatment of conditions and disease | Jul 27, 1999 |
05914322 | Treatment of disease and conditions | Jun 22, 1999 |
05852002 | Treatment of conditions and disease | Dec 22, 1998 |
05792753 | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs | Aug 11, 1998 |
05639738 | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs | Jun 17, 1997 |